EQTIX
Price
$18.51
Change
+$0.11 (+0.60%)
Updated
Aug 21 closing price
Net Assets
1.15B
GVIRX
Price
$20.50
Change
+$0.07 (+0.34%)
Updated
Aug 21 closing price
Net Assets
3.94B
Interact to see
Advertisement

EQTIX vs GVIRX

EQTIX vs GVIRX Comparison Chart in %
View a ticker or compare two or three
VS
EQTIX vs. GVIRX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQTIX is a Buy and GVIRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GVIRX has more cash in the bank: 3.94B vs. EQTIX (1.15B). EQTIX pays higher dividends than GVIRX: EQTIX (8.39) vs GVIRX (0.91). EQTIX was incepted earlier than GVIRX: EQTIX (30 years) vs GVIRX (16 years). GVIRX (0.86) is less costly to investors than EQTIX (0.64). EQTIX is a more actively managed with annual turnover of: 40.00 vs. GVIRX (29.00). GVIRX has a lower initial minimum investment than EQTIX: GVIRX (0) vs EQTIX (1000). EQTIX annual gain was more profitable for investors over the last year : 16.65 vs. GVIRX (15.02). EQTIX return over 5 years is better than : 52.47 vs. GVIRX (34.39).
EQTIXGVIRXEQTIX / GVIRX
Total Expense Ratio0.640.7585%
Annual Report Gross Expense Ratio0.640.8674%
Fund Existence30 years16 years-
Gain YTD11.77913.42188%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B3.94B29%
Annual Yield % from dividends8.390.91926%
Returns for 1 year16.6515.02111%
Returns for 3 years52.2944.11119%
Returns for 5 years52.4734.39153%
Returns for 10 years34.8191.5038%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USIO2.810.15
+5.64%
Usio
PRLD6.630.13
+2.00%
Prelude Therapeutics
FBNC64.700.46
+0.72%
First Bancorp
CACI647.391.04
+0.16%
Caci International CLA
DCOY3.20-0.08
-2.44%
Decoy Therapeutics Inc.